← Back to site
Also see: Before & AfterSystem Flow
PROOF Deal Walkthrough
Pipeline Review
Meridian Systems
Stage 3 · £185K · Jun 26
Playbook: Enterprise MEDDPICC
2 gaps found
Apex Partners
Stage 4 · £320K · May 26
Evidence complete
Northvale Group
Stage 2 · £95K · Jul 26
3 gaps · stalled
Prism Health
Stage 3 · £210K · Jun 26
Evidence complete
Playbook: Enterprise MEDDPICC Stage: Validation Criteria met: 4 / 6 Gate status: Hold Last reviewed: J. Morgan · 2d ago
Step 1 · Evidence Scan
Evidence scan
Meridian Systems Stage 3 · Validation
Problem confirmed call transcript · 18 Feb
Champion identified CRM contact role
ICP match verified firmographic data
Budget range discussed call transcript · 20 Feb
! Single-threaded — 1 active stakeholder CRM contacts
No decision process documented
Step 2 · Diagnostics
Gaps detected
Meridian Systems Stage 3 · Validation
4 of 6 criteria met
! Single-threaded — champion risk
Decision process missing
DL-09 · Single Thread Risk
Only 1 active stakeholder across touchpoints. Recommend mapping buying group before Stage 4 to reduce late-stage stalls.
DL-14 · Decision Process Undefined
No evidence of approval chain, procurement steps, or legal timeline. Stage 3 requires a documented decision process before advancing.
Step 3 · Suggested Write-back
Suggested updates (you confirm)
Suggested CRM Updates
Add next step: "Map buying group — identify economic buyer + procurement contact"
Field: Next_Step__c · Source: DL-09 diagnostic
Flag: "Decision process — requires documentation before Stage 4 advancement"
Field: Evidence_Gap__c · Source: DL-14 diagnostic
Hold stage at: Stage 3 — Validation (2 criteria unmet)
Field: StageName · Reason: evidence gate not passed
3 updates pending
Step 4 · Written Back
Written back + logged
Written to Salesforce
Next step updated — "Map buying group"
Evidence gap flagged — decision process
Stage held at Validation — gate not passed
2026-02-25 14:32:07 UTC · Confirmed by J. Morgan (Manager)
3 fields updated · Source: PROOF diagnostic DL-09, DL-14
Audit ID: PRF-2026-00847

Forecast impact

Evidence-backed coverage: 78% · Exceptions routed: 22%

Next: Northvale Group — 3 gaps · stalled 14 days

PROOF reviews every deal — you only review exceptions.

Scan Diagnose Suggest Write Back

This is what we're building.

PROOF reviews every deal — you only review exceptions. Launching May 2026.

Request walkthrough | Read the series →